Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Clinical trial NCT01241500 · COMPLETED
Trial details
- NCT number
- NCT01241500
- Sponsor
- Traws Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2018-10-03
- Enrollment
- 299
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.